Last reviewed · How we verify
NCT03791931
Cleavage Pattern of Embryos and Oxidative Parameters
NA trial testing oxidative stress measurement in Infertility in 200 participants. Status unknown.
1 January 2021
Quick facts
| Lead sponsor | Carmel Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 200 |
| Start date | 7 July 2019 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 April 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- oxidative stress measurement
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Carmel Medical Center
Who can join
Adults 18 to 45, any sex, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate prospectively whether embryos with abnormal cleaving pattern have different oxidative parameters from normally cleaving embryos, and to analyze whether these parameters have an association with demographic, laboratory and clinical parameters including treatment outcome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03791931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Carmel Medical Center trials
Trials by the same sponsor.
- NCT06604455 — Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime · NA · recruiting
- NCT06612749 — Assessing the Impact of Integrative Medicine on Anxiety and Wellbeing of Healthcare Providers Exposed to Terror or War · NA · recruiting
- NCT06598020 — Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers · NA · active not recruiting
- NCT06590766 — Impact of Acupuncture and Manual Therapies on Patients' Quality-of-life in a Hospital-to-community Continuum · NA · recruiting
- NCT06167057 — POST URS Chemotherapy Instillation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03791931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carmel Medical Center
- Last refreshed: 5 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03791931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing